Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus

Fuminori Sakurai, Toshiyoshi Fujiwara, Hiroyuki Mizuguchia

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

An easy and sensitive detection method for circulating tumor cells (CTC) is expected to be developed because CTC are a promising biomarker for early diagnosis of tumors and prognosis prediction of tumor patients. Our group has already developed a CTC detection method using a conditionally replicating adenovirus (Ad) which efficiently replicates and expresses GFP in telomerase-positive tumor cells. However, malignant tumor cells express much low levels of coxsackievirus and adenovirus receptor (CAR), leading to inefficient infection with a conventional conditionally replicating Ad. In addition, a tiny fraction of normal blood cells, including lymphocytes, express GFP following infection. To overcome these problems, we have developed a next-generation conditionally replicating Ad. The next-generation conditionally replicating Ad possesses the fiber protein derived from Ad serotype 35, leading to efficient infection in both CAR-positive and -negative tumor cells, because the fiber protein of Ad serotype 35 binds to CD46, which is expressed on almost all human cells. Furthermore, sequences complementary to blood cell-specific miRNA (miR-142-3p) were inserted into the 3′ untranslated region of the E1 gene and GFP gene, leading to the suppression of GFP expression in normal blood cells. In this symposium, we will not only introduce the importance of CTC as a biomarker and conventional CTC detection methods but also show our data of the novel CTC detection using the next-generation conditionally replicating Ad.

Original languageEnglish
Pages (from-to)291-296
Number of pages6
JournalYakugaku Zasshi
Volume133
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Circulating Neoplastic Cells
Adenoviridae
Blood Cells
Enterovirus
Neoplasms
Infection
Biomarkers
Telomerase
3' Untranslated Regions
MicroRNAs
Genes
Early Diagnosis
Lymphocytes

Keywords

  • CD46
  • Circulating tumor cell
  • Conditional replication-competent adenovirus
  • Fiber
  • MiRNA

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus. / Sakurai, Fuminori; Fujiwara, Toshiyoshi; Mizuguchia, Hiroyuki.

In: Yakugaku Zasshi, Vol. 133, No. 3, 2013, p. 291-296.

Research output: Contribution to journalArticle

@article{a63892105d7c4081a5f721e3645c7224,
title = "Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus",
abstract = "An easy and sensitive detection method for circulating tumor cells (CTC) is expected to be developed because CTC are a promising biomarker for early diagnosis of tumors and prognosis prediction of tumor patients. Our group has already developed a CTC detection method using a conditionally replicating adenovirus (Ad) which efficiently replicates and expresses GFP in telomerase-positive tumor cells. However, malignant tumor cells express much low levels of coxsackievirus and adenovirus receptor (CAR), leading to inefficient infection with a conventional conditionally replicating Ad. In addition, a tiny fraction of normal blood cells, including lymphocytes, express GFP following infection. To overcome these problems, we have developed a next-generation conditionally replicating Ad. The next-generation conditionally replicating Ad possesses the fiber protein derived from Ad serotype 35, leading to efficient infection in both CAR-positive and -negative tumor cells, because the fiber protein of Ad serotype 35 binds to CD46, which is expressed on almost all human cells. Furthermore, sequences complementary to blood cell-specific miRNA (miR-142-3p) were inserted into the 3′ untranslated region of the E1 gene and GFP gene, leading to the suppression of GFP expression in normal blood cells. In this symposium, we will not only introduce the importance of CTC as a biomarker and conventional CTC detection methods but also show our data of the novel CTC detection using the next-generation conditionally replicating Ad.",
keywords = "CD46, Circulating tumor cell, Conditional replication-competent adenovirus, Fiber, MiRNA",
author = "Fuminori Sakurai and Toshiyoshi Fujiwara and Hiroyuki Mizuguchia",
year = "2013",
doi = "10.1248/yakushi.12-00237-1",
language = "English",
volume = "133",
pages = "291--296",
journal = "Yakugaku Zasshi",
issn = "0031-6903",
publisher = "Pharmaceutical Society of Japan",
number = "3",

}

TY - JOUR

T1 - Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus

AU - Sakurai, Fuminori

AU - Fujiwara, Toshiyoshi

AU - Mizuguchia, Hiroyuki

PY - 2013

Y1 - 2013

N2 - An easy and sensitive detection method for circulating tumor cells (CTC) is expected to be developed because CTC are a promising biomarker for early diagnosis of tumors and prognosis prediction of tumor patients. Our group has already developed a CTC detection method using a conditionally replicating adenovirus (Ad) which efficiently replicates and expresses GFP in telomerase-positive tumor cells. However, malignant tumor cells express much low levels of coxsackievirus and adenovirus receptor (CAR), leading to inefficient infection with a conventional conditionally replicating Ad. In addition, a tiny fraction of normal blood cells, including lymphocytes, express GFP following infection. To overcome these problems, we have developed a next-generation conditionally replicating Ad. The next-generation conditionally replicating Ad possesses the fiber protein derived from Ad serotype 35, leading to efficient infection in both CAR-positive and -negative tumor cells, because the fiber protein of Ad serotype 35 binds to CD46, which is expressed on almost all human cells. Furthermore, sequences complementary to blood cell-specific miRNA (miR-142-3p) were inserted into the 3′ untranslated region of the E1 gene and GFP gene, leading to the suppression of GFP expression in normal blood cells. In this symposium, we will not only introduce the importance of CTC as a biomarker and conventional CTC detection methods but also show our data of the novel CTC detection using the next-generation conditionally replicating Ad.

AB - An easy and sensitive detection method for circulating tumor cells (CTC) is expected to be developed because CTC are a promising biomarker for early diagnosis of tumors and prognosis prediction of tumor patients. Our group has already developed a CTC detection method using a conditionally replicating adenovirus (Ad) which efficiently replicates and expresses GFP in telomerase-positive tumor cells. However, malignant tumor cells express much low levels of coxsackievirus and adenovirus receptor (CAR), leading to inefficient infection with a conventional conditionally replicating Ad. In addition, a tiny fraction of normal blood cells, including lymphocytes, express GFP following infection. To overcome these problems, we have developed a next-generation conditionally replicating Ad. The next-generation conditionally replicating Ad possesses the fiber protein derived from Ad serotype 35, leading to efficient infection in both CAR-positive and -negative tumor cells, because the fiber protein of Ad serotype 35 binds to CD46, which is expressed on almost all human cells. Furthermore, sequences complementary to blood cell-specific miRNA (miR-142-3p) were inserted into the 3′ untranslated region of the E1 gene and GFP gene, leading to the suppression of GFP expression in normal blood cells. In this symposium, we will not only introduce the importance of CTC as a biomarker and conventional CTC detection methods but also show our data of the novel CTC detection using the next-generation conditionally replicating Ad.

KW - CD46

KW - Circulating tumor cell

KW - Conditional replication-competent adenovirus

KW - Fiber

KW - MiRNA

UR - http://www.scopus.com/inward/record.url?scp=84946165166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946165166&partnerID=8YFLogxK

U2 - 10.1248/yakushi.12-00237-1

DO - 10.1248/yakushi.12-00237-1

M3 - Article

VL - 133

SP - 291

EP - 296

JO - Yakugaku Zasshi

JF - Yakugaku Zasshi

SN - 0031-6903

IS - 3

ER -